Profile picture

Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)
Follow
Biography
Claudio Rapezzi is Full Professor of Cardiology at University of Ferrara, Italy. After receiving his MD degree and postgraduate specialization in Cardiovascular Diseases from the University of Bologna, Italy, he worked as Staff cardiologist and Senior Staff cardiologist at the S.Orsola-Malpighi Hospital of Bologna, then becoming Director of the Cardiovascular and Thoracic Department (2008-2013) and Head of the Cardiology Division (2013-2019). Associate Professor of Cardiology since 2001, he held the role of Director of the School of Cardiovascular Diseases at the University of Bologna from 2013 to 2016. He is currently Full Professor of Cardiology at University of Ferrara and Director of the Cardiological Department of Maria Cecilia Hospital GVM Care & research, C
Logo ESC

Contributor content

Management of cardiac transthyretin amyloidosis with or without aortic stenosis
Session
Management of cardiac transthyretin amyloidosis with or without aortic stenosis
27 August 2022
Changing the journey of patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
Session
Changing the journey of patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
27 August 2021
How Should I Treat Cardiac Amyloidosis?
Session
How Should I Treat Cardiac Amyloidosis?
1 September 2020
Hot topics in myocardial and pericardial diseases
Session
Hot topics in myocardial and pericardial diseases
1 September 2019
Cracking the code to a differential diagnosis of cardiac amyloidosis
Session
Cracking the code to a differential diagnosis of cardiac amyloidosis
27 May 2019
Expert Advice - Pragmatic approaches in challenging cardiomyopathies
Session
Expert Advice - Pragmatic approaches in challenging cardiomyopathies
27 August 2018
Have you considered cardiac amyloidosis in your patients?
Session
Have you considered cardiac amyloidosis in your patients?
25 August 2018
Considering cardiac amyloidosis in our patients: why is it so important?
Session
Considering cardiac amyloidosis in our patients: why is it so important?
28 May 2018
The myocarditis challenge
Session
The myocarditis challenge
30 August 2016

ESC 365 is supported by